TY  - GEN
AU  - da Silva-Coelho,Pedro
AU  - Kroeze,Leonie I
AU  - Yoshida,Kenichi
AU  - Koorenhof-Scheele,Theresia N
AU  - Knops,Ruth
AU  - van de Locht,Louis T
AU  - de Graaf,Aniek O
AU  - Massop,Marion
AU  - Sandmann,Sarah
AU  - Dugas,Martin
AU  - Stevens-Kroef,Marian J
AU  - Cermak,Jaroslav
AU  - Shiraishi,Yuichi
AU  - Chiba,Kenichi
AU  - Tanaka,Hiroko
AU  - Miyano,Satoru
AU  - de Witte,Theo
AU  - Blijlevens,Nicole M A
AU  - Muus,Petra
AU  - Huls,Gerwin
AU  - van der Reijden,Bert A
AU  - Ogawa,Seishi
AU  - Jansen,Joop H
TI  - Clonal evolution in myelodysplastic syndromes
SN  - 2041-1723
PY  - 2018///1115
KW  - Aged
KW  - Angiogenesis Inhibitors
KW  - therapeutic use
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Bone Marrow Cells
KW  - drug effects
KW  - Clonal Evolution
KW  - Disease Management
KW  - Disease Progression
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Follow-Up Studies
KW  - GTP Phosphohydrolases
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Lenalidomide
KW  - Male
KW  - Membrane Proteins
KW  - Middle Aged
KW  - Monitoring, Physiologic
KW  - Mutation
KW  - Myelodysplastic Syndromes
KW  - drug therapy
KW  - Proto-Oncogene Proteins p21(ras)
KW  - Thalidomide
KW  - analogs & derivatives
KW  - Tumor Suppressor Protein p53
KW  - Exome Sequencing
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/ncomms15099
ER  -